Caroline Cochran

Co-founder Caroline Cochran sold 200,000 shares for $10,585,600.00 on 2026-07-01

Caroline Cochran, who was COO at the time, executed four separate sales totaling 200,000 shares for $10,585,600.00 at prices ranging from $52.30 to $53.71 on 2026-07-01, reducing her holdings by 27.2%. This transaction occurs against a backdrop of material headwinds: the company reported full-year net income of $-33,065,000.00, and the stock has declined 28.7% over the past 30 days while trading at -73.0% from its 52-week high of $193.84. Notably, Cochran's five prior sales at OKLO (on 2026-06-01) all posted significant negative 30-day returns (-19.3% to -24.1%), establishing a pattern of selling into downward price momentum at this ticker. This large, multi-tranche liquidation by a co-founder during a period of sustained stock weakness and operating losses warrants close investor attention to whether this signals confidence in near-term recovery or reflects deeper concerns about the company's trajectory.

Co-founder Caroline Cochran sells 200,000 OKLO shares for $13.7M via scheduled 10b5-1 plan on 2026-06-01

Caroline Cochran, who was COO at the time of this transaction, executed 8 separate sales totaling 200,000 shares for $13,657,879.60 at prices ranging from $64.99 to $70.45, reducing her holdings by 25.8% from 776,483 to 576,483 shares. This transaction is part of a pre-arranged 10b5-1 trading plan adopted on 2025-03-31, making it a scheduled execution rather than a discretionary trade. Notably, the company reported a net loss of $33,065,000 over its most recent full fiscal year, indicating ongoing unprofitability despite the multi-billion-dollar market cap. At the same ticker, Cochran's prior 5 sells (all on 2026-05-01) each subsequently declined 3.2% to 5.7% over both 30-day and 90-day periods, whereas her cross-ticker track record of 20 prior sells shows average positive returns of +14.7% at 30 days and +16.9% at 90 days—establishing a material divergence between her general timing accuracy and her outcomes at OKLO specifically.

Co-founder Cochran sells 200,000 shares ($14.0M) via pre-arranged 10b5-1 plan at $70.23 avg, down 24.5% from holdings

Cochran Caroline, who was COO at the time of filing, executed 6 separate sales totaling 200,000 shares for $14,046,610.27 on 2026-05-01, reducing her holdings by 24.5% to 616,483 shares post-transaction. This sale was executed under a pre-arranged 10b5-1 trading plan adopted on 2025-03-31, meaning the timing and volume were scheduled in advance rather than discretionary. The blended average sale price of $70.23 compares to the current price of $70.40 and sits within the 52-week range of $23.74–$174.14, approximately 59.6% below the 52-week high. Notably, the company reported a negative net income of $-64,217,000.00 over its most recent full fiscal year, an important context for understanding the capital structure and operational performance against which this insider holding reduction should be evaluated.

Co-Founder Caroline Cochran sells 200,000 OKLO shares (23.4% of holdings) at $48.41–$51.20 as stock drops 72.4% from 52-week high

Caroline Cochran, Co-Founder and COO of Oklo Inc., executed 10 separate sales on 2026-04-01 totaling 200,000 shares (200.0K shares) for $10,069,852.10, reducing her holdings by 23.4% from 856,483 to 656,483 shares. The blended average transaction price of $50.35 occurred as the stock traded at $48.13 current price, representing a -72.4% decline from the 52-week high of $174.14. The company is unprofitable, posting net income of $-29,722,000.00 over its most recent full fiscal year. Her prior trades at OKLO show consistently negative 30-day returns (-21.8%, -25.0%, -25.3%), and her cross-ticker track record across 20 prior sells averaged -20.1% 30-day returns, suggesting a pattern of selling into weakness rather than strength. The current stock price at $48.13 already sits below the transaction prices achieved on 2026-04-01, signaling further deterioration post-transaction.

Co-Founder/former COO Cochran Caroline sold 200,000 shares for $12.7M across 12 transactions on 2026-03-02 under 10b5-1 plan

Cochran Caroline, who was then-COO and co-founder, executed 12 separate sales totaling 200,000 shares for $12,658,097.15 at prices ranging from $60.44 to $64.33, with a blended average of $63.29 per share. This was a scheduled disposition under a pre-arranged 10b5-1 trading plan adopted on 2025-03-31, meaning the sales were not discretionary timing decisions. The sale reduced her holdings from 1,510,000 shares to 1,310,000 shares, representing a -13.2% reduction in position size. The multi-tranche execution across a narrow price range ($60.44–$64.33) is consistent with algorithmic or systematic execution under the pre-established plan rather than reactive market conditions.

OKLO Co-Founder Caroline Cochran sells 200,000 shares for $14,992,025.35 under 10b5-1 plan

Cochran Caroline, who was COO at the time, executed 12 separate sales totaling 200,000 shares for $14,992,025.35 on 2026-02-02 across a narrow price range ($73.81 to $78.20 blended average $74.96). This transaction is part of a pre-arranged 10b5-1 trading plan adopted on 2025-03-31, making it scheduled rather than discretionary. Post-transaction, Cochran's holdings declined from 1,550,000 shares to 1,350,000 shares, a reduction of 12.9%. The multi-tranche execution across incrementally higher prices and the structured nature of the 10b5-1 plan indicate this was a predetermined liquidation schedule, not a response to current market conditions.

Co-founder Caroline Cochran sells 91,628 shares for $10.2M under scheduled 10b5-1 plan

Caroline Cochran, who was COO at the time of the transaction, executed 6 separate sales totaling 91,628 shares for $10,247,603.25 on 2026-01-09, with a blended average price of $111.84 per share. This sale reduced her holdings from 1,481,628 shares to 1,390,000 shares, representing a 6.2% reduction in her position. Importantly, this transaction is part of a pre-arranged 10b5-1 trading plan adopted on 2025-03-31, meaning it was scheduled rather than discretionary and does not reflect a real-time market timing or conviction signal. Post-transaction holdings of 1.39M shares indicate Cochran retains substantial equity exposure to Oklo Inc.

Cochran Caroline, Co-Founder/then-COO, executes 20 sales totaling 328,372 shares for $32,481,835.58 under pre-arranged 10b5-1 plan adopted 2025-03-31.

Cochran Caroline, who was COO at the time, executed 20 separate sales totaling 328,372 shares for $32,481,835.58 across January 7–8, 2026, at prices ranging from $93.79 to $100.06 per share. This divestiture represents 18.9% of her pre-transaction holdings, reducing her position from 1,737,446 shares to 1,409,074 shares. The sales were conducted under a pre-arranged 10b5-1 trading plan adopted on 2025-03-31, meaning they were scheduled transactions executed according to a predetermined formula rather than discretionary timing decisions. Because this activity was contractually arranged in advance, it does not reflect a contemporaneous judgment about the company's valuation or business trajectory.

Cochran, co-founder and then-COO, sold 200,000 shares for $18,058,200 under 10b5-1 plan

Cochran Caroline, who was COO at the time of this filing, executed 2 separate sales totaling 200,000 shares for $18,058,200 on 2026-01-05 at $90.29 per share. This transaction occurred pursuant to a pre-arranged 10b5-1 trading plan adopted on 2025-03-31, meaning the sale was scheduled rather than discretionary. The sale reduced her holdings by 11.9%, bringing her post-transaction holdings to 1,480,000 shares from 1,680,000 shares. As a scheduled transaction under a pre-established plan, this sale carries no timing signal and should be viewed as part of a predetermined execution schedule rather than a responsive market decision.

Co-founder Cochran sells 840,000 shares for $69.2M under pre-arranged 10b5-1 plan adopted March 2025

Cochran Caroline, who was COO at the time, executed 12 separate sales totaling 840,000 shares for $69,150,555.09 on 2025-12-22, reducing her stake from 2,420,000 shares to 1,580,000 shares (a 34.7% reduction in holdings). The sales were executed across a range of prices from $80.84 to $85.70, with a blended average price of $82.32, and were part of a pre-arranged 10b5-1 trading plan adopted on 2025-03-31, indicating the timing and volume were scheduled in advance rather than discretionary. This substantial divestiture by a co-founder represents a material reduction in insider exposure to OKLO, though the scheduled nature of the plan prevents attribution to market-timing judgment or changes in conviction at the time of execution.